Anticonvulsant effects of isomeric nonimidazole histamine H₃ receptor antagonists

References

• BrigoFAussererHTezzonFNardoneRWhen one plus one makes three: the quest for rational antiepileptic polytherapy with supraadditive anticonvulsant efficacyEpilepsy Behav201327343944223591263
   PubMed Web of Science ®Google Scholar
• SchmidtDThe clinical impact of new antiepileptic drugs after a decade of use in epilepsyEpilepsy Res2002501–2213212151114
   PubMed Web of Science ®Google Scholar
• ElgerCEHelmstaedterCKurthenMChronic epilepsy and cognitionLancet Neurol200431166367215488459
   PubMed Web of Science ®Google Scholar
• HermannBMeadorKJGaillardWDCramerJACognition across the lifespan: antiepileptic drugs, epilepsy, or both?Epilepsy Behav20101711519931492
   PubMed Web of Science ®Google Scholar
• HaasHLSergeevaOASelbachOHistamine in the nervous systemPhysiol Rev20088831183124118626069
   PubMed Web of Science ®Google Scholar
• ArrangJMGarbargMSchwartzJCAuto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature198330259118328376188956
   PubMed Web of Science ®Google Scholar
• BrownREStevensDRHaasHLThe physiology of brain histamineProg Neurobiol200163663767211164999
   PubMed Web of Science ®Google Scholar
• ArrangJMGarbargMSchwartzJCAutoinhibition of histamine synthesis mediated by presynaptic H3-receptorsNeuroscience19872311491572446202
   PubMed Web of Science ®Google Scholar
• SchlickerEFinkKDetznerMGothertMHistamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptorsJ Neural Transm Gen Sect19939311108396945
   PubMed Web of Science ®Google Scholar
• SchlickerEBetzRGothertMHistamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortexNaunyn Schmiedebergs Arch Pharmacol198833755885903412497
   PubMed Web of Science ®Google Scholar
• SadekBStarkHCherry-picked ligands at histamine receptor subtypesNeuropharmacology2016106567326581501
   PubMed Web of Science ®Google Scholar
• YokoyamaHThe role of central histaminergic neuron system as an anticonvulsive mechanism in developing brainBrain Dev200123754254711701252
   PubMed Web of Science ®Google Scholar
• ScherklRHashemAFreyHHHistamine in brain – its role in regulation of seizure susceptibilityEpilepsy Res1991102–31111181817952
   PubMed Web of Science ®Google Scholar
• KameiCIshizawaKKakinokiHFukunagaMHistaminergic mechanisms in amygdaloid-kindled seizures in ratsEpilepsy Res19983031871949657646
   PubMed Web of Science ®Google Scholar
• ChenZLiWDZhuLJShenYJWeiEQEffects of histidine, a precursor of histamine, on pentylenetetrazole-induced seizures in ratsActa Pharmacol Sin200223436136611931695
   PubMed Web of Science ®Google Scholar
• YawataITanakaKNakagawaYWatanabeYMurashimaYLNakanoKRole of histaminergic neurons in development of epileptic seizures in EL miceBrain Res Mol Brain Res20041321131715548424
   PubMedGoogle Scholar
• TakanoTSakaueYSokodaTSeizure susceptibility due to antihistamines in febrile seizuresPediatr Neurol201042427727920304332
   PubMed Web of Science ®Google Scholar
• MiyataISaegusaHSakuraiMSeizure-modifying potential of histamine H1 antagonists: a clinical observationPediatr Int201153570670821261789
   PubMed Web of Science ®Google Scholar
• HaruyamaWFuchigamiTNoguchiYThe relationship between drug treatment and the clinical characteristics of febrile seizuresWorld J Pediatr20084320220518822929
   PubMed Web of Science ®Google Scholar
• ZolalyMAHistamine H1 antagonists and clinical characteristics of febrile seizuresInt J Gen Med2012527728122505826
   PubMedGoogle Scholar
• SadekBSaadASadeqAJalalFStarkHHistamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseasesBehav Brain Res201631241543027363923
   PubMed Web of Science ®Google Scholar
• GemkowMJDavenportAJHarichSEllenbroekBACesuraAHallettDThe histamine H3 receptor as a therapeutic drug target for CNS disordersDrug Discov Today2009149–1050951519429511
   PubMed Web of Science ®Google Scholar
• BhowmikMKhanamRVohoraDHistamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectivesBr J Pharmacol201216771398141422758607
   PubMed Web of Science ®Google Scholar
• Kasteleijn-Nolst TreniteDParainDGentonPMasnouPSchwartzJCHirschEEfficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: dose-dependent effects in the human photosensitivity modelEpilepsy Behav2013281667023665640
   PubMed Web of Science ®Google Scholar
• SanderKKottkeTStarkHHistamine H3 receptor antagonists go to clinicsBiol Pharm Bull200831122163218119043195
   PubMed Web of Science ®Google Scholar
• WitkinJMNelsonDLSelective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous systemPharmacol Ther2004103112015251226
   PubMed Web of Science ®Google Scholar
• Van der SchyfCJGeldenhuysWJYoudimMBMultifunctional drugs with different CNS targets for neuropsychiatric disordersJ Neurochem20069941033104817054441
   PubMed Web of Science ®Google Scholar
• von CoburgYKottkeTWeizelLLigneauXStarkHPotential utility of histamine H3 receptor antagonist pharmacophore in antipsychoticsBioorg Med Chem Lett200919253854219091563
   PubMed Web of Science ®Google Scholar
• KeithJMBarbierAJWilsonSJDual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophoresBioorg Med Chem Lett200717195325532917765543
   PubMed Web of Science ®Google Scholar
• AltenbachRJBlackLAStrakhovaMIDiaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in painJ Med Chem201053217869787320945906
   PubMed Web of Science ®Google Scholar
• SadekBSchwedJSSubramanianDNon-imidazole histamine H3 receptor ligands incorporating antiepileptic moietiesEur J Med Chem20147726927924650714
   PubMed Web of Science ®Google Scholar
• IsenseeKAmonMGarlapatiAFluorinated non-imidazole histamine H3 receptor antagonistsBioorg Med Chem Lett20091982172217519286376
   PubMed Web of Science ®Google Scholar
• StocksMJCheshireDRReynoldsREfficient and regiospecific one-pot synthesis of substituted 1,2,4-triazolesOrg Lett20046172969297115330660
   PubMed Web of Science ®Google Scholar
• MeierGApeltJReichertUInfluence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonistsEur J Pharm Sci200113324925911384847
   PubMed Web of Science ®Google Scholar
• BaekJBHarrisFWDevelopment of an improved synthetic route to an AB phenylquinoxaline monomerJ Polym Sci A Polym Chem2005434801814
   Web of Science ®Google Scholar
• SanderKKottkeTHoffendCFirst metal-containing histamine H3 receptor ligandsOrg Lett201012112578258120446742
   PubMed Web of Science ®Google Scholar
• SanderKKottkeTWeizelLStarkHKojic acid derivatives as histamine H(3) receptor ligandsChem Pharm Bull (Tokyo)201058101353136120930404
   PubMed Web of Science ®Google Scholar
• SadekBKuderKSubramanianDAnticonvulsive effect of nonimidazole histamine H3 receptor antagonistsBehav Pharmacol201425324525224776492
   PubMed Web of Science ®Google Scholar
• SadekBSaadASubramanianDShafiullahMLazewskaDKiec-KononowiczcKAnticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult ratsNeuropharmacology2016106465526525191
   PubMed Web of Science ®Google Scholar
• SadekBSchreebASchwedJSWeizelLStarkHDrug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligandsDrug Des Devel Ther2014814991513
   PubMed Web of Science ®Google Scholar
• SadekBShehabSWiecekMAnticonvulsant properties of histamine H3 receptor ligands belonging to N-substituted carbamates of imidazopropanolBioorg Med Chem Lett201323174886489123891186
   PubMed Web of Science ®Google Scholar
• ChengYPrusoffWHRelationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochem Pharmacol19732223309931084202581
   PubMed Web of Science ®Google Scholar
• SchlotterKBoecklerFHubnerHGmeinerPFancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profilesJ Med Chem200548113696369915916420
   PubMed Web of Science ®Google Scholar
• van StaverenDRMetzler-NolteNBioorganometallic chemistry of ferroceneChem Rev2004104125931598515584693
   PubMed Web of Science ®Google Scholar
• SchibliRSchubigerPACurrent use and future potential of organometallic radiopharmaceuticalsEur J Nucl Med Mol Imaging200229111529154212397472
   PubMed Web of Science ®Google Scholar
• LazewskaDLigneauXSchwartzJCSchunackWStarkHKiec-KononowiczKEther derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonistsBioorg Med Chem200614103522352916466921
   PubMed Web of Science ®Google Scholar
• SadekBKhanianSSAshoorAEffects of antihistamines on the function of human alpha7-nicotinic acetylcholine receptorsEur J Pharmacol201474630831625445036
   PubMed Web of Science ®Google Scholar
• BahiASadekBNurulainSMLazewskaDKiec-KononowiczKThe novel non-imidazole histamine H receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in micePhysiol Behav201515118919726169446
   PubMed Web of Science ®Google Scholar
• BahiASadekBSchwedSJWalterMStarkHInfluence of the novel histamine H(3) receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in micePsychopharmacology (Berl)20132281859523474889
   PubMed Web of Science ®Google Scholar
• BahiASchwedJSWalterMStarkHSadekBAnxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H(3) receptor antagonist ST-1283Drug Des Devel Ther20148627637
   PubMed Web of Science ®Google Scholar
• LoscherWCritical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugsSeizure201120535936821292505
   PubMed Web of Science ®Google Scholar
• Branco CdosSScolaGRodriguesADAnticonvulsant, neuroprotective and behavioral effects of organic and conventional yerba mate (Ilex paraguariensis St. Hil.) on pentylenetetrazol-induced seizures in Wistar ratsBrain Res Bull201292606823270878
   PubMed Web of Science ®Google Scholar
• SowemimoAAAdioOFageyinboSAnticonvulsant activity of the methanolic extract of Justicia extensa T. AndersJ Ethnopharmacol2011138369769922004892
   PubMed Web of Science ®Google Scholar
• SanchetiJShaikhMFChaudhariRCharacterization of anticonvulsant and antiepileptogenic potential of thymol in various experimental modelsNaunyn Schmiedebergs Arch Pharmacol20133871596624065087
   PubMed Web of Science ®Google Scholar
• CoppolaGArcieriSD’AnielloALevetiracetam in submaximal subcutaneous pentylentetrazol-induced seizures in ratsSeizure201019529629920399683
   PubMed Web of Science ®Google Scholar
• RogawskiMATofighyAWhiteHSMatagneAWolffCCurrent understanding of the mechanism of action of the antiepileptic drug lacosamideEpilepsy Res201511018920525616473
   PubMed Web of Science ®Google Scholar
• ZolkowskaDDhirAKrishnanKCoveyDFRogawskiMAAnticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural formsPsychopharmacology (Berl)2014231173325333224705905
   PubMed Web of Science ®Google Scholar
• ChoiDStablesJPKohnHSynthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivativesJ Med Chem1996399190719168627614
   PubMed Web of Science ®Google Scholar
• KohnHConleyJDLeanderJDMarked stereospecificity in a new class of anticonvulsantsBrain Res198845723713753219563
   PubMed Web of Science ®Google Scholar
• KakinokiHIshizawaKFukunagaMFujiiYKameiCThe effects of histamine H3-receptor antagonists on amygdaloid kindled seizures in ratsBrain Res Bull19984654614659739010
   PubMed Web of Science ®Google Scholar
• VohoraDPalSNPillaiKKThioperamide, a selective histamine H3 receptor antagonist, protects against PTZ-induced seizures in miceLife Sci20006622PL297PL30110834305
   PubMed Web of Science ®Google Scholar